NDC 68180-411 – Irbesartan
Irbesartan 150 mg/1 · Tablet · Oral
Product NDC68180-411
Product details
- Brand name
- Irbesartan
- Generic name
- Irbesartan
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA201531
- Marketed since
- October 23, 2012
- Listing expires
- December 31, 2026
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Active ingredients
- Irbesartan 150 mg/1
Package NDC codes (0)
| Package NDC | Description | Since |
|---|
Recalls mentioning this NDC
- D-0086-2022 Nov 10, 2021 · Class II
CGMP Deviations: impurity N-nitrosoirbesartan detected in API - D-0087-2022 Nov 10, 2021 · Class II
CGMP Deviations: impurity N-nitrosoirbesartan detected in API - D-0088-2022 Nov 10, 2021 · Class II
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Other Irbesartan products
- 50090-2978 Irbesartan 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-7622 Irbesartan 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-6938 Irbesartan 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-2017 Irbesartan 300 mg/1 · Tablet · A-S Medication Solutions
- 50090-1284 Irbesartan 150 mg/1 · Tablet · A-S Medication Solutions
- 62332-043 Irbesartan 300 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-041 Irbesartan 75 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-042 Irbesartan 150 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 46708-439 Irbesartan 75 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-441 Irbesartan 300 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-440 Irbesartan 150 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 65162-284 Irbesartan 75 mg/1 · Tablet · Amneal Pharmaceuticals LLC